Another Blockbuster Bites The Dust

[Anonymous]

Bad news for bitapertin for schizophrenia this weekend.

This is yet another failed blockbuster broad-market product. We are hitting 0 for 3:
- Diabetes
- HDL Cholesterol
- Schizophrenia

Only one left is Alzheimers

Should we just stick to little specialty niche markets and leave these broad markets to big pharma?

 

[Anonymous]

Bad news for bitapertin for schizophrenia this weekend.

This is yet another failed blockbuster broad-market product. We are hitting 0 for 3:
- Diabetes
- HDL Cholesterol
- Schizophrenia

Only one left is Alzheimers

Should we just stick to little specialty niche markets and leave these broad markets to big pharma?

The Roche curse remember posicor and xenical both were to be billion dollar drugs!

 

[Anonymous]

Bad news for bitapertin for schizophrenia this weekend.

This is yet another failed blockbuster broad-market product. We are hitting 0 for 3:
- Diabetes
- HDL Cholesterol
- Schizophrenia

Only one left is Alzheimers

Should we just stick to little specialty niche markets and leave these broad markets to big pharma?

Huh???We ARE big pharma! We are the 7th largest drug company in the world. Yes, we ARE big pharma!

 

[Anonymous]

It's starting to look like if it isn't oncology related, it doesn't make it to prime time here. They're trying to create new molecules with new modes of action and novel designs which is about as high risk as starting a company from scratch.

 

[Anonymous]

Bad news for bitapertin for schizophrenia this weekend.

This is yet another failed blockbuster broad-market product. We are hitting 0 for 3:
- Diabetes
- HDL Cholesterol
- Schizophrenia

Only one left is Alzheimers

Should we just stick to little specialty niche markets and leave these broad markets to big pharma?

add Mircera

 

[Anonymous]

The Roche curse remember posicor and xenical both were to be billion dollar drugs!

Xenical is not part of the Roche curse. The drug is still Rx and OTC.

 

[Anonymous]

Xenical is not part of the Roche curse. The drug is still Rx and OTC.

Xenical is earning 1billion+ annually, just not for Roche. Its now called Alli, and I believe its owned by P&G

 

[Anonymous]

Xenical is earning 1billion+ annually, just not for Roche. Its now called Alli, and I believe its owned by P&G

I doubt that sales in the US is anywhere near 1billion, maybe worldwide. And Roche/Gene still own the molecule, it is licensed to GSK for Alli

 

[Anonymous]

Did Roche's Press Release Jeopardize The Ongoing Clinical Trials For Its Schizophrenia Drug, Bitopertin?

http://www.forbes.com/sites/johnlam...hizophrenia-drug-bitopertin/?partner=yahootix

 

[Anonymous]

http://www.reuters.com/article/2014/03/03/roche-metmab-idUSL6N0M00B620140303

 

[Anonymous]

Expect more failures! The sick liberal mentality prevails in SSF, priority is not hiring the best but ...... we all know!

 

[Anonymous]

Don't forget Tasmar for Parkinson's. That was supposed to be a 2 billion dollar drug and it just killed a few people! no big deal, the swiss just keep on reaching into the cash vault. Don't forget the vitamin scandal either that took place in early 2000. Those F$%$#rs ran to the FDA to pay a one billion fine for price fixing with their other european counterparts. Thats who you're working for!! They'll cut your balls off for a nickel, and laugh!!! Roche SUCKS!!!!!!!